Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 22, 2024

SELL
$145.6 - $158.88 $7,280 - $7,944
-50 Reduced 11.9%
370 $57,000
Q3 2023

Oct 18, 2023

SELL
$155.75 - $174.48 $13,861 - $15,528
-89 Reduced 17.49%
420 $65,000
Q2 2023

Jul 14, 2023

BUY
$154.35 - $166.11 $771 - $830
5 Added 0.99%
509 $84,000
Q1 2023

Apr 10, 2023

SELL
$151.05 - $180.26 $4,833 - $5,768
-32 Reduced 5.97%
504 $78,000
Q4 2022

Jan 23, 2023

SELL
$160.2 - $179.79 $9,131 - $10,248
-57 Reduced 9.61%
536 $0
Q3 2022

Oct 18, 2022

BUY
$161.33 - $179.52 $1,290 - $1,436
8 Added 1.37%
593 $97,000
Q2 2022

Aug 10, 2022

BUY
$168.19 - $186.01 $4,541 - $5,022
27 Added 4.84%
585 $104,000
Q1 2022

Apr 08, 2022

SELL
$158.14 - $179.59 $10,437 - $11,852
-66 Reduced 10.58%
558 $99,000
Q4 2021

Jan 20, 2022

BUY
$155.93 - $173.01 $97,300 - $107,958
624 New
624 $107,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $431B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Level Financial Advisors, Inc. Portfolio

Follow Level Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Level Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Level Financial Advisors, Inc. with notifications on news.